Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:CYCC’

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: Tang Capital Partners LP and Cyclacel Pharmaceuticals Inc. (CYCC)

Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC): Kevin C. Tang’s Tang Capital Partners LP filed an amended 13D. You can check out Tang Capital Management......(read more)
30 Funniest Science Jokes, Puns, and Humor Quotes Ever

Why Cyclacel Pharmaceuticals Inc (CYCC) is in the Spotlight

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares have popped over 30% this afternoon due to momentum traders buying the stock for technical reasons.......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Here’s What Is Happening In Financial Markets Today?

1. US Stock Market: “Wall Street stocks on Monday were aiming to start the second quarter with tepid gains. Investors were set to take cues from a handful......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Here’s What Happened With Cyclacel Pharmaceuticals Inc (CYCC) And Nivalis Therapeutics Inc (NVLS)

This week was a good one for a few biotechs, but not so great for others. Two in particular have just put out news relating to trials for their lead investigative......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Here’s Why Cyclacel Pharmaceuticals Inc (CYCC) Could Have A Rough December

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) soared throughout the US session on Thursday, gaining as much as 60% across the day. The company dipped into......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Movers and Shakers In Biotech: Cyclacel Pharmaceuticals Inc (CYCC) and Corium International Inc (CORI)

Yet again, we’ve had a busy start to the week in biotech. A number of companies are moving on news or data reported at the close of last week, and others......(read more)
Baidu Inc (ADR) (NASDAQ:BIDU), Icon, app, Symbol, Sign, logo, smarphone

Why Are Traders Piling Into These Stocks?

Crude futures are up more than 2% this morning as weakness in the dollar and supply disturbances boost sentiment. Not surprisingly, all three major indexes......(read more)
Acadia Healthcare Company Inc (NASDAQ:ACHC)

ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday’s intraday trading and hit a 52-week high of $46.48. The price action......(read more)
OncoGenex Pharmaceuticals Inc (OGXI)

Tang Capital Management Is Getting Out of OncoGenex Pharmaceuticals Inc (OGXI) and Cyclacel Pharmaceuticals Inc (CYCC)

Kevin C. Tang‘s Tang Capital Management has decreased its position it two pharmaceutical companies. The $200 million hedge fund recently decreased......(read more)
Jim Chanos puppeteer

Jeremy Green, Redmile Group Drop Cyclacel Pharmaceuticals Like It’s Hot

Jeremy Green, Redmile Group: In a passive 13G filing with the SEC just now, the San Francisco-based Redmile Group, managed by Jeremy Green, has closed......(read more)
Affymax, Inc. (NASDAQ:AFFY)

Hedge Funds Are Selling Affymax, Inc. (AFFY) – Northwest Biotherapeutics, Inc (NWBO), Celsion Corporation (CLSN)

Is Affymax, Inc. (NASDAQ:AFFY) the right pick for your portfolio? Hedge funds are becoming less confident. The number of bullish hedge fund bets dropped......(read more)